← Back to Search

Aim 1. Focus Groups for Brain Tumor

N/A
Waitlist Available
Led By Maria Swartz, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Oncologists who are caring for AYA cancer survivors or Survivorship care providers who actively engage with AYA cancer survivors
AYA cancer survivors age 15-39 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial will test a new active video game-centered lifestyle physical activity intervention for adolescents and young adults who are at very high-risk for steep functional decline after surgery for a central nervous system tumor.

Eligible Conditions
  • Brain Tumor
  • Exercise
  • Tumors

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
The study is looking for oncologists or survivorship care providers who work with young adult cancer survivors.
Select...
The clinical trial is looking for young adult cancer survivors between the ages of 15 and 39.
Select...
You haven't been active enough, meaning you haven't exercised for at least 150 minutes with moderate to high intensity in the past week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Life Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Group I: Aim 2. Pilot randomized controlled trial:Experimental Treatment1 Intervention
AYAs with primary benign or malignant central nervous system tumors (n=80 patients approached, with n= 40 participants consented and randomized to the intervention (n=20) or usual care control group (n=20)) treated at MDACC, any gender and race, who are ≤1-year post-surgery for a central nervous system tumor.
Group II: Aim 1. Focus GroupsExperimental Treatment1 Intervention
Healthcare providers (n=16-24 participants in 4 focus groups) from MD Anderson Cancer Center (MDACC). AYAs with primary benign or malignant central nervous system tumors (n=16-24 participants in 4 focus groups) treated at MDACC.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,765 Total Patients Enrolled
Maria Swartz, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

POWER UP Clinical Trial Eligibility Overview. Trial Name: NCT05308407 — N/A
Brain Tumor Research Study Groups: Aim 1. Focus Groups, Aim 2. Pilot randomized controlled trial:
Brain Tumor Clinical Trial 2023: POWER UP Highlights & Side Effects. Trial Name: NCT05308407 — N/A
POWER UP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05308407 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current cap on recruitment for this experiment?

"Affirmative. The information found on clinicaltrials.gov suggests that this medical research, which was initially made available on May 4th 2022 is actively recruiting participants. 88 volunteers are needed to be sourced from a single site."

Answered by AI

Are there opportunities to join this research program presently?

"According to the clinicaltrials.gov page, this medical trial is actively searching for participants as of today's date. It was first made available on May 4th, 2022 and has since been updated on May 10th, 2022."

Answered by AI
~7 spots leftby Oct 2025